Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
-34.85%
20%
—
—
60%
—
5 Years
Score—
Net Growth-34.85%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev Trend60%
Revenue Consistency—
Madrigal Pharmaceuticals Inc fundamental performance
Across Madrigal Pharmaceuticals Inc's full reported history, from 2007 to 2025, revenue grew from $ 743K to $ 958M and net income went from -$ 63M to -$ 288M. Revenue increased in 32% of the years measured; net income in 21%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 536.20 | — |
1 Year2025-08-12 | $ 359.00 | 49.36% |
5 Years2021-08-12 | $ 85.43 | 6x |
10 Years2016-08-12 | $ 7.53 | 71x |
All Time2007-02-06 | $ 318.15 | 68.54% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2007-02-06 |
|---|---|---|---|---|---|
| Price | $ 536.20 | $ 359.00 | $ 85.43 | $ 7.53 | $ 318.15 |
| Return | — | 49.36% | 6x | 71x | 68.54% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.28B | -$ 325M | $ 838M |
| 2025 | $ 958M | -$ 288M | $ 983M |
| 2024 | $ 180M | -$ 465M | $ 926M |
| 2023 | $ 0.00 | -$ 373M | $ 634M |
| 2022 | $ 0.00 | -$ 295M | $ 358M |
| 2021 | $ 0.00 | -$ 241M | $ 270M |
| 2020 | $ 0.00 | -$ 197M | $ 284M |
| 2019 | $ 0.00 | -$ 72M | $ 439M |
| 2018 | $ 0.00 | -$ 32M | $ 483M |
| 2017 | $ 350K | -$ 31M | $ 191M |
| 2016 | $ 0.00 | -$ 26M | $ 40M |
| 2015 | $ 0.00 | -$ 6M | $ 66M |
| 2014 | $ 0.00 | -$ 86M | $ 97M |
| 2013 | $ 0.00 | -$ 90M | $ 91M |
| 2012 | $ 147K | -$ 62M | $ 100M |
| 2011 | $ 7M | -$ 47M | $ 39M |
| 2010 | $ 14M | -$ 37M | $ 50M |
| 2009 | $ 144M | $ 79M | $ 44M |
| 2008 | $ 2M | -$ 92M | $ 73M |
| IPO2007 | $ 743K | -$ 63M | $ 115M |
Explore beyond MDGL
You're looking at Madrigal Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
